Newer Antibiotics Show No Clear Benefit for Staph Infections

Published Date: 28 Jul 2026

A new meta-analysis finds ceftaroline and ceftobiprole monotherapy show no clear advantage over standard therapy for non-urinary Staphylococcus aureus infections.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mental health risk persists years after cancer diagnosis

2.

Breast cancer prevention: How nurse practitioners and physician assistants can help

3.

For treatment, the majority of cancer patients choose complementary therapies.

4.

Cancer mortality continuing to decline, says report

5.

Doctors say lung cancer is still the deadliest cancer, but hope is growing


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot